SAN ANTONIO—Tamoxifen is highly effective in reducing the recurrence of breast cancer in the adjuvant setting and as palliative treatment in the metastatic setting, but not all women benefit from tamoxifen. Resistance to the beneficial effects of tamoxifen may be in part explained by genetic...